Karyopharm Therapeutics
KPTI
KPTI
75 hedge funds and large institutions have $135M invested in Karyopharm Therapeutics in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $187M → $135M (-$53M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
75
Holding in Top 10
–
Calls
$310K
Puts
$176K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.41M | |
| 3 | +$857K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$549K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$335K |
Top Sellers
| 1 | -$6.75M | |
| 2 | -$3.97M | |
| 3 | -$765K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$599K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
-$442K |